 "vaccine")
India’s drug regulator approved two new Covid-19 vaccines, along with an oral antiviral pill, on Tuesday, a day after the subject expert committee (SEC) gave its green signal. Vaccines Corbevax (Biological E) and Covovax (Serum Institute of India and Novavax), and antiviral Molnupiravir (Merck and Ridgeback) were given the nod.
The move also increases the options before India to allow the mixing of vaccines for a third shot, in case the health minstry decides to do so. The Centre had recently allowed a third shot after nine months of the second dose to health care, frontline workers, and senior citizens with
